Addition of Immunomodulators Cuts Vascular Inflammation in RA

MONDAY, Dec. 12, 2022 -- For patients with rheumatoid arthritis (RA), the addition of a tumor necrosis factor (TNF) inhibitor (TNFi) or addition of sulfasalazine and hydroxychloroquine (triple therapy) to methotrexate results in clinically important...